Condition

Chronic Graft-Versus-Host Disease

Treatments and trials tagged Chronic Graft-Versus-Host Disease, with the same country and access zoom as New Developments.

All New Developments

Chronic Graft-Versus-Host Disease breakthroughs

All countriesUnited StatesCanadaUnited KingdomJapanChinaAustraliaSwitzerlandEuropean UnionNewestPatient Stories
FDA ApprovedUnited States

First FDA-Approved Cell Therapy to Reduce Chronic Graft-Versus-Host Disease

TREGZI (allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq) — donor cell transplant product to help adults with blood cancers stay free of chronic graft-versus-host disease

FDA approval on 30 June 2026 for TREGZI (allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq) suspension — a donor-matched cell…

This is for adults with blood cancers who need a matched-donor stem cell transplant after intensive…